中国生物类似药景观的现状
1Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing, China.
概括
中国领导着全球生物类似药的开发,提供更多的生物治疗选择. 本综述探讨了中国的生物类似物领域,监管进展,挑战以及潜在的临床试验适应性.
科学领域:
- 生物制药科学 生物制药科学
- 监管科学 监管科学
- 卫生经济学 卫生经济学
背景情况:
- 生物仿制药改善了医疗保健的获取,并降低了生物疗法的成本.
- 包括世卫组织在内的全球监管机构为生物类似开发制定了框架.
- 中国是生物类似药研发 (R&D) 的重要参与者.
研究的目的:
- 总结中国生物仿制药研发和注册的情况.
- 审查中国生物类似药监管科学和指导方针的演变.
- 讨论挑战,并提出中国生物类似药开发的战略,包括临床试验设计.
主要方法:
- 关于中国生物类似药研发的文献综述.
- 对生物类似药的中国监管准则的分析.
- 对生物类似开发的挑战和建议解决方案的审查.
主要成果:
- 中国在开发的生物类似药的种类和数量方面已成为全球领导者.
- 在生物类似药研发方面进行了大量投资,中国的监管复杂度不断提高.
- 确定中国生物仿制药发展道路中的关键挑战.
结论:
- 中国在生物类似药研发和监管方面的进步对于全球获取生物制剂至关重要.
- 调整或放弃对比性临床疗效研究可能会加速生物类似药物的批准.
- 需要进一步发展监管科学,以优化中国的生物类似途径.
更多相关视频
09:16Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
1.1K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
356
相关概念视频
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
